GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
P

Ping AN Healthcare and Technology Co 1833.HK · HKD

Health Care · HKEX · 🇭🇰 Hong Kong

Compare

5.76

-2.70%

Close of 9 Nov 2026, in HKD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CNY, from our data supplier.

FY2025

Revenue

CN¥6.37bn

FY2016FY2025

Net income

CN¥441.9m

FY2016FY2025

Free cash flow

CN¥456.2m

FY2016FY2025

Shareholders' equity

CN¥11.55bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueCN¥6.37bnCN¥5.60bnCN¥5.44bnCN¥7.23bnCN¥8.54bnCN¥7.99bnCN¥5.90bnCN¥3.89bnCN¥2.18bnCN¥700.4m
Gross profitCN¥2.06bnCN¥1.77bnCN¥1.76bnCN¥1.95bnCN¥1.99bnCN¥2.17bnCN¥1.36bnCN¥1.06bnCN¥712.7mCN¥295.3m
Research and developmentCN¥394.5m————————CN¥350.0m
Operating incomeCN¥113.6m−CN¥103.7m−CN¥669.8m−CN¥845.7m−CN¥1.91bn−CN¥1.07bn−CN¥1.25bn−CN¥1.29bn−CN¥1.16bn−CN¥868.6m
Net incomeCN¥441.9mCN¥94.8m−CN¥375.6m−CN¥740.6m−CN¥1.79bn−CN¥1.10bn−CN¥854.5m−CN¥1.06bn−CN¥1.17bn−CN¥882.8m
Diluted earnings per share0.210.09-0.35-0.69-1.62-1.05-0.80-1.06-1.39-0.83

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsCN¥15.41bnCN¥19.54bnCN¥19.24bnCN¥19.96bnCN¥20.82bnCN¥21.61bnCN¥14.41bnCN¥14.41bnCN¥6.95bnCN¥4.88bn
Cash and short-term investmentsCN¥8.12bnCN¥13.41bnCN¥13.21bnCN¥11.80bnCN¥11.81bnCN¥15.76bnCN¥8.60bnCN¥8.37bnCN¥6.05bnCN¥3.42bn
Total liabilitiesCN¥3.87bnCN¥15.37bnCN¥3.79bnCN¥4.29bnCN¥4.42bnCN¥3.15bnCN¥3.16bnCN¥2.45bnCN¥2.26bnCN¥2.11bn
DebtCN¥58.6mCN¥55.5mCN¥104.1mCN¥176.5mCN¥201.3mCN¥114.0mCN¥95.6m——CN¥550.0m
Shareholders' equityCN¥11.55bnCN¥4.18bnCN¥15.47bnCN¥15.67bnCN¥16.40bnCN¥18.44bnCN¥11.23bnCN¥11.88bnCN¥4.70bnCN¥2.76bn
Shares outstanding2,134m1,084m1,080m1,079m1,105m1,049m1,067m1,000m836m1,067m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsCN¥501.5mCN¥115.7m−CN¥329.4m−CN¥943.9m−CN¥1.63bn−CN¥1.28bn−CN¥587.1m−CN¥1.26bn−CN¥563.5m−CN¥306.3m
Capital spending−CN¥45.3m−CN¥39.9m−CN¥50.0m−CN¥40.1m−CN¥103.8m−CN¥85.2m−CN¥154.9m−CN¥230.1m−CN¥14.1m−CN¥114.3m
Free cash flowCN¥456.2mCN¥75.8m−CN¥379.4m−CN¥984.0m−CN¥1.74bn−CN¥1.37bn−CN¥742.0m−CN¥1.49bn−CN¥577.5m−CN¥420.6m
Dividends paid−CN¥4.43bn—————————

Latest quarters

By quarter end

Jun 2026Dec 2025Jun 2025Dec 2024Jun 2024Dec 2023Jun 2023Dec 2022
RevenueCN¥2.85bnCN¥3.45bnCN¥2.91bnCN¥3.16bnCN¥2.44bnCN¥2.85bnCN¥2.59bnCN¥3.93bn
Gross profitCN¥1.10bnCN¥1.09bnCN¥977.7mCN¥989.2mCN¥784.6mCN¥923.5mCN¥832.9mCN¥1.07bn
Operating incomeCN¥189.6mCN¥12.6mCN¥101.0m−CN¥55.4m−CN¥48.3m−CN¥254.0m−CN¥528.8m−CN¥577.2m
Net incomeCN¥251.9mCN¥285.7mCN¥156.2mCN¥28.9mCN¥66.0m−CN¥90.8m−CN¥284.8m−CN¥202.1m
Diluted earnings per share0.120.130.070.030.06-0.08-0.26-0.19
Cash from operationsCN¥75.0mCN¥375.0mCN¥74.0mCN¥272.0m−CN¥157.0m−CN¥251.0m−CN¥78.0m−CN¥840.0m
Capital spending−CN¥8.0m−CN¥41.0m−CN¥4.0m−CN¥27.0m−CN¥12.0m−CN¥30.0m−CN¥19.0m−CN¥25.0m
Free cash flowCN¥67.0mCN¥334.0mCN¥70.0mCN¥245.0m−CN¥169.0m−CN¥281.0m−CN¥97.0m−CN¥865.0m
Total assetsCN¥15.23bnCN¥15.41bnCN¥15.08bnCN¥19.54bnCN¥18.86bnCN¥19.24bnCN¥19.40bnCN¥19.96bn
Cash and short-term investmentsCN¥8.39bnCN¥8.12bnCN¥9.04bnCN¥13.41bnCN¥12.99bnCN¥13.21bnCN¥13.40bnCN¥11.80bn
DebtCN¥25.1mCN¥58.6mCN¥65.7mCN¥64.6mCN¥69.0mCN¥121.2mCN¥169.6mCN¥205.5m
Shareholders' equityCN¥11.74bnCN¥11.55bnCN¥11.30bnCN¥4.18bnCN¥15.58bnCN¥15.47bnCN¥15.55bnCN¥15.67bn

Financial ratios

Data as of 23 Sept 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2016FY2015
Gross margin32.4%31.7%32.3%26.9%23.3%27.2%——
Operating margin1.8%-1.9%-12.3%-11.7%-22.4%-13.4%——
Net margin6.9%1.7%-6.9%-10.3%-21.0%-13.8%——
Return on equity3.8%2.3%-2.4%-4.7%-10.9%-6.0%——
Return on assets2.9%0.5%-2.0%-3.7%-8.6%-5.1%——
Free cash flow yield3.6%2.0%-3.6%-11.8%-19.5%-16.1%——
Revenue growth13.7%2.9%-24.7%-15.4%6.8%35.5%——
Earnings growth366.1%-125.2%-49.3%-58.6%62.2%29.2%——
Current ratio2.70x1.02x4.30x3.61x3.47x5.72x——
Debt to equity0.00x0.01x0.00x0.01x0.01x0.00x——
Equity ratio75.0%21.4%80.4%78.5%78.8%85.3%——
Interest coverage36.45x-26.20x-83.54x-65.36x-151.75x-153.37x——
R&D as a share of sales6.2%—————50.0%36.0%
Buybacks as a share of market value-97.0%-0.3%-0.2%2.4%-5.4%1.7%——

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-4.1%-4.5%34.7%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin32.1%30.6%28.4%28.2%
Operating margin0.1%-6.1%-10.9%-17.4%
Net margin4.5%-2.4%-8.4%-14.4%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Price to earnings59.062.0-17.8-10.8-6.1-30.9-24.6-9.0
Price to sales4.11.11.21.11.34.33.62.5

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years. Last went ex-dividend on 6 Dec 2024.

FY2024
Paid in the year0.097

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.